×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
西安交通大学 [46]
复旦大学上海医学院 [15]
中国医学科学院 北京... [9]
中国农业科学院 [7]
昆明医科大学 [3]
南京地理与湖泊研究所 [1]
更多...
内容类型
期刊论文 [72]
会议论文 [14]
发表日期
2022 [1]
2019 [4]
2018 [11]
2017 [6]
2016 [5]
2015 [1]
更多...
学科主题
畜牧、动物医学、狩猎... [1]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共86条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Contrasting assembly mechanisms explain the biogeographic patterns of benthic bacterial and fungal communities on the Tibetan Plateau
期刊论文
ENVIRONMENTAL RESEARCH, 2022, 卷号: 214
作者:
Zhao, Baohui
;
Jiao, Congcong
;
Wang, Shuren
;
Zhao, Dayong
;
Jiang, Cuiling
收藏
  |  
浏览/下载:1/0
  |  
提交时间:2023/12/19
Charge transport properties in organic D-A mixed-stack complexes based on corannulene and sumanene derivatives-a theoretical study
期刊论文
ORGANIC ELECTRONICS, 2019, 卷号: 68
作者:
Wang, Huan
;
Wang, Yuanyuan
;
Jin, Xingyi
;
Bai, Fu-Quan
;
Chen, Xi
收藏
  |  
浏览/下载:67/0
  |  
提交时间:2019/12/05
DFT
Corannulene
Sumanene
D-A mixed-stack cocrystal
Charge transport property
The REACH Trial: A Randomized Controlled Trial Assessing the Safety and Effectiveness of the Spiration (R) Valve System in the Treatment of Severe Emphysema
期刊论文
RESPIRATION, 2019, 卷号: 97, 期号: 5
作者:
Li, Shiyue
;
Wang, Guangfa
;
Wang, Changhui
;
Gao, Xinglin
;
Jin, Faguang
收藏
  |  
浏览/下载:31/0
  |  
提交时间:2019/12/05
Chronic obstructive pulmonary disease
Emphysema
Bronchoscopic lung volume reduction
Spiration (R) Valve System
Endobronchial valves
Intrabronchial valves
Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303.
期刊论文
Thoracic cancer, 2019, 卷号: 10, 页码: 551-556
作者:
Si Xiaoyan
;
Zhang Li
;
Wang Hanping
;
Zhang Xiaotong
;
Wang Mengzhao
收藏
  |  
浏览/下载:34/0
  |  
提交时间:2019/11/19
non-small cell lung cancer
multi-target tyrosine kinase inhibitor
Adverse event
anlotinib
Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303
期刊论文
2019, 卷号: 10, 期号: 3, 页码: 551-556
作者:
Si, Xiaoyan
;
Zhang, Li
;
Wang, Hanping
;
Zhang, Xiaotong
;
Wang, Mengzhao
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2020/01/03
Adverse event
anlotinib
multi-target tyrosine kinase inhibitor
non-small cell lung cancer
Prognostic factors of refractory NSCLC patients receiving anlotinib hydrochloride as the third- or further-line treatment
期刊论文
CANCER BIOLOGY & MEDICINE, 2018, 卷号: 15, 期号: 4
作者:
Wang, Jing
;
Zhao, Yizhuo
;
Wang, Qiming
;
Zhang, Li
;
Shi, Jianhua
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/04
Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non-Small Cell Lung Cancer The ALTER 0303 Phase 3 Randomized Clinical Trial
期刊论文
JAMA ONCOLOGY, 2018, 卷号: 4, 期号: 11
作者:
Han, Baohui
;
Li, Kai
;
Wang, Qiming
;
Zhang, Li
;
Shi, Jianhua
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/04
Genetic polymorphism of SLC31A1 is associated with clinical outcomes of platinum-based chemotherapy in non-small-cell lung cancer patients through modulating microRNA-mediated regulation.
期刊论文
Oncotarget, 2018, 卷号: 9, 期号: 35
作者:
Sun Chang
;
Zhang Zhuojun
;
Qie Jingbo
;
Wang Yi
;
Qian Ji
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2019/12/05
NSCLC
SLC31A1
SNP
microRNA
pharmacogenetics
Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non-Small Cell Lung Cancer: The ALTER 0303 Phase 3 Randomized Clinical Trial.
期刊论文
JAMA Oncology, 2018, 卷号: 4, 期号: 11, 页码: 1569-1575
作者:
Han, Baohui*
;
Li, Kai*
;
Wang, Qiming
;
Zhang, Li
;
Shi, Jianhua
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2019/12/03
anlotinib
non-small-cell lung carcinoma
Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non-Small Cell Lung Cancer: The ALTER 0303 Phase 3 Randomized Clinical Trial.
期刊论文
JAMA oncology, 2018, 卷号: 4, 页码: 1569-1575
作者:
Han Baohui
;
Li Kai
;
Wang Qiming
;
Zhang Li
;
Shi Jianhua
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2019/11/26
©版权所有 ©2017 CSpace - Powered by
CSpace